. . . . . . . . . . . . . . "a(CHEBI:\"nitric oxide\") -> cat(p(RGD:Cyp2d1))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "As for DEM, both NO donors increased (up to 3.5-fold) the recovery of the CYP2D1-mediated metabolite dextrorphan (DOR) in the outlet perfusate. However, this was associated with a simultaneous decrease (50-75%) in the excretion of the metabolite into the bile, thus resulting in no change in the overall recovery of DOR as a result of NO donor treatment." . . "Selventa" . . . . "2014-07-03T14:30:42.727+02:00"^^ . . .